Heron Therapeutics HRTX
NASDAQ HRTX
$0.36 -0.01 (-3.96%)
At close: Nov 11, 2026 · 4:00 PM EST

Heron Therapeutics (HRTX) Return on Capital Employed [ROCE] (2009 - 2026)

Updated

Heron Therapeutics' Return on Capital Employed [ROCE] came in at -6.92% for Q2 2026, down 0.40 percentage points from the prior quarter.

Analysis

Heron Therapeutics (HRTX) Return on Capital Employed [ROCE] (2009 - 2026) Analysis & Trends

For FY2025, Heron Therapeutics' Return on Capital Employed [ROCE] was -1.71%, up 6.74 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has increased in each of the last three years, with a five-year change of +67.29 percentage points (FY2020 to FY2025).
  • Going back by year, Return on Capital Employed [ROCE] was -8.45% in FY2024 (+61.98 pp), -70.44% in FY2023 (+18.69 pp), -89.12% in FY2022 (-4.88 pp) and -84.24% in FY2021 (-15.24 pp).
  • The Q2 2026 figure represents the lowest quarterly Return on Capital Employed [ROCE] since Q4 2024.
  • Year-over-year, Return on Capital Employed [ROCE] increased in five of the last six quarters, with an average year-over-year change of +35.77 percentage points.
  • The fastest year-over-year change in Return on Capital Employed [ROCE] over five years came in Q2 2024 (a gain of 77.06 percentage points), and the weakest in Q2 2022 (a drop of 61.42 percentage points).
  • Business Quant data shows HRTX's Return on Capital Employed [ROCE] at -6.51% (Q1 2026), -1.62% (Q4 2025) and 1.06% (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Heron Therapeutics 70.40 Mn -87.13 Mn 26.29 Mn -5.57%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -5.57%
Jun 30, 2026 -6.92%
Mar 31, 2026 -6.51%
Dec 31, 2025 -1.62%
Sep 30, 2025 1.06%
Mar 31, 2025 -2.45%
Dec 31, 2024 -8.51%
Sep 30, 2024 -19.36%
Jun 30, 2024 -33.69%
Mar 31, 2024 -56.86%
Dec 31, 2023 -75.68%
Sep 30, 2023 -89.14%
Jun 30, 2023 -110.76%
Mar 31, 2023 -91.64%
Dec 31, 2022 -97.52%
Sep 30, 2022 -126.67%
Jun 30, 2022 -145.75%
Mar 31, 2022 -116.23%
Dec 31, 2021 -84.43%
Sep 30, 2021 -73.72%
API Access

Heron Therapeutics Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=HRTX&period=max&api_key=YOUR_API_KEY